ZEPP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Zepp Health Corp (ZEPP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show a bearish trend, the financial performance is weak with declining net income and EPS, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. Holding off on investment or monitoring for better entry points is advised.
The stock is in a bearish trend with MACD negatively expanding (-0.323), RSI at 29.691 (neutral zone), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 18.454), with resistance levels at R1: 23.898 and R2: 25.579.
Revenue increased by 78.49% YoY in Q3 2025, indicating strong top-line growth.
Net income dropped by 87.80% YoY, EPS declined by 80.00% YoY, and gross margin fell by 6.03% YoY. No recent news or significant trading trends from hedge funds, insiders, or Congress. Technical indicators are bearish.
In Q3 2025, revenue increased significantly to $75.79M (up 78.49% YoY), but net income dropped to -$1.62M (down 87.80% YoY), and EPS fell to -0.01 (down 80.00% YoY). Gross margin also declined to 38.16% (down 6.03% YoY).
No recent analyst ratings or price target changes available.
